Loading...
  • smokers
  • Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. (aafp.org)
  • From a public health perspective, there is a trade-off between e-cigarettes that provide high levels of nicotine, high satisfaction and more effects on craving for tobacco, but may also be addictive, and e-cigarettes that contain less nicotine and are less addictive, but are also less satisfactory and less efficient at relieving craving and at helping dependent smokers quit smoking. (nih.gov)
  • prevalence
  • The 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) sought to determine the prevalence of drinking, smoking, and associated disorders in the general population. (ebscohost.com)
  • In December of 2016, leaders and advocates in public health, behavioral health, and tobacco control came together to continue collaboration and integration among the fields focused on reducing smoking prevalence among people with mental illnesses and substance use disorders in Minnesota. (lung.org)
  • Beckham JC, Kirby AC, Feldman ME, Hertzberg MA, Moore SD, Crawford AL, Davidson JRT, Fairbank JA (1997) Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder. (springer.com)
  • To describe the association between active, environmental tobacco smoke ETS exposure and the prevalence of eustachian tube dysfunction ETD in the U.S. pediatric population. (duhnnae.com)
  • quit
  • Of course, these individuals should be regularly advised to completely quit using all tobacco products. (simpleandpractical.com)
  • To explore how e-cigarettes attenuate craving for tobacco, in e-cigarette users who recently quit smoking. (nih.gov)
  • Craving
  • Craving, or a strong desire or urge to use tobacco. (mentalhealth.com)
  • After full criteria for tobacco use disorder were previously met, none of the criteria for tobacco use disorder have been met for at least 3 months but for less than 12 months (with the exception that the criterion, "Craving, or a strong desire or urge to use tobacco," may be met). (mentalhealth.com)
  • Explaining the effects of electronic cigarettes on craving for tobacco in recent quitters. (nih.gov)
  • The strongest attenuation of craving for tobacco was obtained by using higher nicotine concentrations in refill liquids, modular systems (rather than unmodified devices), and high voltage batteries. (nih.gov)
  • Participants who reported the strongest effects on craving for tobacco were the most dependent on the e-cigarette and had the strongest urges to vape. (nih.gov)
  • mortality
  • Lack of targeted and effective strategies to control tobacco consumption contributes to a large burden of cardiovascular disorders in low- and middle-income countries, where cardiovascular disorders have become the leading cause of morbidity and mortality. (ahajournals.org)
  • In this review, we evaluate the epidemiology of tobacco use in low- and middle-income countries and assess the public health policies needed to control tobacco use in such regions for the prevention of cardiovascular disorders and other tobacco-related morbidities and mortality. (ahajournals.org)
  • withdrawal
  • It typically includes a strong desire to use tobacco, difficulties in controlling its use, persisting in its use despite harmful consequences, a higher priority given to drug use than to other activities and obligations, increased tolerance, and a physical withdrawal state. (mentalhealth.com)
  • The individual is taking a long-term maintenance medication, such as nicotine replacement medication, and no criteria for tobacco use disorder have been met for that class of medication (except tolerance to, or withdrawal from, the nicotine replacement medication). (mentalhealth.com)
  • The characteristic withdrawal syndrome for tobacco (refer to Criteria A and B of the criteria set for tobacco withdrawal). (therapybooker.com)
  • In addition to no increase in smoking abstinence, we saw no effect of OROS-MPH for tobacco withdrawal symptom relief and no change in smoking rates was observed in the OROS-MPH group compared to the placebo group. (duhnnae.com)
  • comorbidity
  • Breslau N, Davis GC, Peterson EL, Schultz LR (2000) A second look at comorbidity in victims of trauma: the posttraumatic stress disorder-major depression connection. (springer.com)
  • Mental Health
  • ALA change perspective - Four mental health practitioners explain why incorporating tobacco treatment into their services is important and part of their contribution to providing health services for clients. (lung.org)
  • Objective
  • Objective: To identify and analyse the themes employed by the Asian based transnational tobacco companies to construct a tobacco culture among Asian young men and women. (ebscohost.com)
  • Research
  • Research examining synergistic interactions among these conditions, biological vulnerabilities shared among them, and the direct impact of tobacco use on the pathophysiology of PTSD, depression, and pain is needed. (springer.com)
  • among
  • Asian yuppies…are always looking for something new and different": creating a tobacco culture among young Asians. (ebscohost.com)